• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于价值医疗保健方法的流感疫苗接种评估

Influenza Vaccination Assessment according to a Value-Based Health Care Approach.

作者信息

Calabrò Giovanna Elisa, D'Ambrosio Floriana, Fallani Elettra, Ricciardi Walter

机构信息

Section of Hygiene, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

VIHTALI (Value in Health Technology and Academy for Leadership & Innovation), Spinoff of Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

出版信息

Vaccines (Basel). 2022 Oct 8;10(10):1675. doi: 10.3390/vaccines10101675.

DOI:10.3390/vaccines10101675
PMID:36298540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9612276/
Abstract

BACKGROUND

Seasonal influenza has a considerable public health impact, and vaccination is the key to preventing its consequences. Our aim was to describe how the value of influenza vaccination is addressed in the scientific literature considering a new value framework based on four pillars (personal, allocative, technical, and societal value).

METHODS

A systematic review was conducted by querying three databases. The analysis was performed on international studies focused on influenza vaccination value, and the four value pillars were taken into consideration for their description.

RESULTS

Overall, 40 studies were considered. Most of them focused on influenza vaccination in the general population (27.5%), emphasizing its value for all age groups. Most studies addressed technical value (70.4%), especially in terms of economic models and cost drivers to be considered for the economic evaluations of influenza vaccines, and societal value (63%), whereas few dealt with personal (37%) and allocative values (22.2%).

CONCLUSIONS

The whole value of influenza vaccination is still not completely recognized. Knowledge and communication of the whole value of influenza vaccination is essential to guide value-based health policies. To achieve this goal, it is necessary to implement initiatives that involve all relevant stakeholders.

摘要

背景

季节性流感对公众健康有重大影响,接种疫苗是预防其后果的关键。我们的目的是根据一个基于四个支柱(个人价值、分配价值、技术价值和社会价值)的新价值框架,描述科学文献中如何阐述流感疫苗接种的价值。

方法

通过查询三个数据库进行系统综述。对聚焦于流感疫苗接种价值的国际研究进行分析,并考虑四个价值支柱进行描述。

结果

总体而言,共纳入40项研究。其中大多数聚焦于普通人群的流感疫苗接种(27.5%),强调其对所有年龄组的价值。大多数研究涉及技术价值(70.4%),特别是在流感疫苗经济评估应考虑的经济模型和成本驱动因素方面,以及社会价值(63%),而涉及个人价值(37%)和分配价值(22.2%)的研究较少。

结论

流感疫苗接种的整体价值仍未得到充分认识。了解并传播流感疫苗接种的整体价值对于指导基于价值的卫生政策至关重要。为实现这一目标,有必要实施涉及所有相关利益攸关方的举措。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee6/9612276/2e46f712fe74/vaccines-10-01675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee6/9612276/2e46f712fe74/vaccines-10-01675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee6/9612276/2e46f712fe74/vaccines-10-01675-g001.jpg

相似文献

1
Influenza Vaccination Assessment according to a Value-Based Health Care Approach.基于价值医疗保健方法的流感疫苗接种评估
Vaccines (Basel). 2022 Oct 8;10(10):1675. doi: 10.3390/vaccines10101675.
2
The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.疫苗接种的价值:依据基于价值的医疗保健方法构建科学证据。
Front Public Health. 2022 Mar 9;10:786662. doi: 10.3389/fpubh.2022.786662. eCollection 2022.
3
Recommendations to drive a value-based decision-making on vaccination.关于推动疫苗接种决策的价值导向的建议。
Expert Rev Vaccines. 2022 Mar;21(3):289-296. doi: 10.1080/14760584.2022.2021880. Epub 2022 Jan 4.
4
Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.健康成年劳动者季节性流感疫苗接种:经济评价综述。
Drugs. 2012 Jan 1;72(1):35-48. doi: 10.2165/11597310-000000000-00000.
5
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南(2021—2022年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
6
Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.中低收入国家的流感疫苗:系统评价经济评估。
Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31.
7
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南(2020—2021年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1555-1576. doi: 10.3760/cma.j.cn112338-20200904-01126.
8
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.德国增加 6 个月及以上儿童普遍接种季节性四价流感疫苗(QIV)的成本效用分析。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2058304. doi: 10.1080/21645515.2022.2058304. Epub 2022 Apr 29.
9
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
10
Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.使用减毒活流感鼻内疫苗对儿童进行接种——通过卫生技术评估进行分析与评价
GMS Health Technol Assess. 2014 Oct 30;10:Doc03. doi: 10.3205/hta000119. eCollection 2014.

引用本文的文献

1
Addressing influenza in Bangladesh: closing evidence and policy gaps with strategic interventions.应对孟加拉国的流感:通过战略干预缩小证据与政策差距
Lancet Reg Health Southeast Asia. 2025 May 19;37:100592. doi: 10.1016/j.lansea.2025.100592. eCollection 2025 Jun.
2
A study of booster dose influenza vaccination responses compared to standard dose in lupus patients: an open-labeled, randomized controlled study.狼疮患者中加强剂量流感疫苗接种反应与标准剂量的比较研究:一项开放标签的随机对照研究。
Clin Exp Med. 2025 Apr 9;25(1):109. doi: 10.1007/s10238-025-01639-6.
3
[Not Available].

本文引用的文献

1
Seasonal influenza in children: Costs for the health system and society in Europe.儿童季节性流感:欧洲卫生系统和社会的成本。
Influenza Other Respir Viruses. 2022 Sep;16(5):820-831. doi: 10.1111/irv.12991. Epub 2022 Apr 15.
2
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment.《意大利老年人用新型四价佐剂流感疫苗:卫生技术评估》。
Int J Environ Res Public Health. 2022 Mar 31;19(7):4166. doi: 10.3390/ijerph19074166.
3
The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.
[无可用内容]
J Prev Med Hyg. 2024 Jun 30;65(2 Suppl 1):E1-E159. doi: 10.15167/2421-4248/jpmh2024.65.2s1. eCollection 2024 Sep.
4
Health Technology Assessment of Vaccines in Italy: History and Review of Applications.意大利疫苗的卫生技术评估:历史与应用综述
Vaccines (Basel). 2024 Sep 24;12(10):1090. doi: 10.3390/vaccines12101090.
5
The economic and fiscal impact of incremental use of cell-based quadrivalent influenza vaccine for the prevention of seasonal influenza among healthcare workers in Italy.细胞基四价流感疫苗在意大利用于预防季节性流感的医护人员中的增量使用的经济和财政影响。
Health Res Policy Syst. 2024 Mar 22;22(1):36. doi: 10.1186/s12961-024-01122-w.
6
The application of metagenomic next-generation sequencing in pathogen diagnosis: a bibliometric analysis based on Web of Science.宏基因组下一代测序在病原体诊断中的应用:基于 Web of Science 的文献计量分析。
Front Cell Infect Microbiol. 2023 Aug 3;13:1112229. doi: 10.3389/fcimb.2023.1112229. eCollection 2023.
7
Influenza vaccination from the perspective of health care workers at university hospitals.从高校医院医护人员的角度看流感疫苗接种。
PLoS One. 2023 Jul 21;18(7):e0288470. doi: 10.1371/journal.pone.0288470. eCollection 2023.
8
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion.≥65岁成年人强化流感疫苗成本效益分析中的真实世界证据:文献综述与专家意见
Vaccines (Basel). 2023 Jun 11;11(6):1089. doi: 10.3390/vaccines11061089.
9
What Type of Person Should I Be? About the Appeal to Virtues in Public Health Interventions.我应该成为什么样的人?论公共卫生干预中的美德诉求。
Vaccines (Basel). 2023 Mar 30;11(4):767. doi: 10.3390/vaccines11040767.
疫苗接种的价值:依据基于价值的医疗保健方法构建科学证据。
Front Public Health. 2022 Mar 9;10:786662. doi: 10.3389/fpubh.2022.786662. eCollection 2022.
4
Effects of Ownership Text Message Wording and Reminders on Receipt of an Influenza Vaccination: A Randomized Clinical Trial.流感疫苗接种短信措辞及提醒的效果:一项随机临床试验
JAMA Netw Open. 2022 Feb 1;5(2):e2143388. doi: 10.1001/jamanetworkopen.2021.43388.
5
Recommendations to drive a value-based decision-making on vaccination.关于推动疫苗接种决策的价值导向的建议。
Expert Rev Vaccines. 2022 Mar;21(3):289-296. doi: 10.1080/14760584.2022.2021880. Epub 2022 Jan 4.
6
Manifesto on the Value of Adult Immunization: "We Know, We Intend, We Advocate".《成人免疫接种价值宣言》:“我们知晓,我们意愿,我们倡导”
Vaccines (Basel). 2021 Oct 22;9(11):1232. doi: 10.3390/vaccines9111232.
7
Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study.在冠状病毒(COVID-19)大流行期间癌症患者接种流感疫苗的价值:一项横断面研究。
Support Care Cancer. 2021 Nov;29(11):6225-6231. doi: 10.1007/s00520-021-06204-x. Epub 2021 Apr 10.
8
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
9
Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health.精准医学与公共卫生:有效且可持续健康面临的新挑战。
J Pers Med. 2021 Feb 16;11(2):135. doi: 10.3390/jpm11020135.
10
Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.德国季节性流感常规儿童疫苗接种的成本效益分析。
Value Health. 2021 Jan;24(1):32-40. doi: 10.1016/j.jval.2020.05.022. Epub 2020 Nov 5.